Epitope selection and development of peptide based vaccines to treat cancer

Esteban Celis, Alessandro Sette, Howard M. Grey

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Cytotoxic T lymphocytes recognize peptides that associate with class I major histocompatibility complex molecules. Since cytotoxic T cells have the capacity to recognize and destroy tumor cells, identification of epitopes recognized by these cells in tumor-associated antigens would allow the production of compounds for the treatment of cancer. Here we review some of the approaches being explored to identify tumor-associated antigens and to develop peptide-based vaccines that induce cytotoxic T lymphocytes against specific tumors.

Original languageEnglish (US)
Pages (from-to)329-336
Number of pages8
JournalSeminars in Cancer Biology
Volume6
Issue number6
DOIs
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Subunit Vaccines
Epitopes
Cytotoxic T-Lymphocytes
Neoplasm Antigens
Neoplasms
Major Histocompatibility Complex
T-Lymphocytes
Peptides

Keywords

  • Cytotoxic T-cell epitopes
  • Epitopes
  • HLA-binding peptides
  • Peptide vaccine
  • Tumor-associated antigens
  • Tumor-associated CTL

ASJC Scopus subject areas

  • Cancer Research

Cite this

Epitope selection and development of peptide based vaccines to treat cancer. / Celis, Esteban; Sette, Alessandro; Grey, Howard M.

In: Seminars in Cancer Biology, Vol. 6, No. 6, 01.01.1995, p. 329-336.

Research output: Contribution to journalArticle

Celis, Esteban ; Sette, Alessandro ; Grey, Howard M. / Epitope selection and development of peptide based vaccines to treat cancer. In: Seminars in Cancer Biology. 1995 ; Vol. 6, No. 6. pp. 329-336.
@article{347d2983a24f4720a240d1a7112de893,
title = "Epitope selection and development of peptide based vaccines to treat cancer",
abstract = "Cytotoxic T lymphocytes recognize peptides that associate with class I major histocompatibility complex molecules. Since cytotoxic T cells have the capacity to recognize and destroy tumor cells, identification of epitopes recognized by these cells in tumor-associated antigens would allow the production of compounds for the treatment of cancer. Here we review some of the approaches being explored to identify tumor-associated antigens and to develop peptide-based vaccines that induce cytotoxic T lymphocytes against specific tumors.",
keywords = "Cytotoxic T-cell epitopes, Epitopes, HLA-binding peptides, Peptide vaccine, Tumor-associated antigens, Tumor-associated CTL",
author = "Esteban Celis and Alessandro Sette and Grey, {Howard M.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1016/1044-579X(95)90002-0",
language = "English (US)",
volume = "6",
pages = "329--336",
journal = "Seminars in Cancer Biology",
issn = "1044-579X",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Epitope selection and development of peptide based vaccines to treat cancer

AU - Celis, Esteban

AU - Sette, Alessandro

AU - Grey, Howard M.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Cytotoxic T lymphocytes recognize peptides that associate with class I major histocompatibility complex molecules. Since cytotoxic T cells have the capacity to recognize and destroy tumor cells, identification of epitopes recognized by these cells in tumor-associated antigens would allow the production of compounds for the treatment of cancer. Here we review some of the approaches being explored to identify tumor-associated antigens and to develop peptide-based vaccines that induce cytotoxic T lymphocytes against specific tumors.

AB - Cytotoxic T lymphocytes recognize peptides that associate with class I major histocompatibility complex molecules. Since cytotoxic T cells have the capacity to recognize and destroy tumor cells, identification of epitopes recognized by these cells in tumor-associated antigens would allow the production of compounds for the treatment of cancer. Here we review some of the approaches being explored to identify tumor-associated antigens and to develop peptide-based vaccines that induce cytotoxic T lymphocytes against specific tumors.

KW - Cytotoxic T-cell epitopes

KW - Epitopes

KW - HLA-binding peptides

KW - Peptide vaccine

KW - Tumor-associated antigens

KW - Tumor-associated CTL

UR - http://www.scopus.com/inward/record.url?scp=0029421213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029421213&partnerID=8YFLogxK

U2 - 10.1016/1044-579X(95)90002-0

DO - 10.1016/1044-579X(95)90002-0

M3 - Article

VL - 6

SP - 329

EP - 336

JO - Seminars in Cancer Biology

JF - Seminars in Cancer Biology

SN - 1044-579X

IS - 6

ER -